Literature DB >> 29527124

Strategies for the Synthesis of the Halenaquinol and Xestoquinol Families of Natural Products.

Gregg M Schwarzwalder1, Christopher D Vanderwal1.   

Abstract

The halenaquinol family of naphthoquinol natural products includes a few closely related polycyclic compounds that feature an activated, electrophilic furan ring. This motif is likely responsible for the rich biological activity attributed to these secondary metabolites. Their interesting structures-related via their electrophilic furan to the biologically important furanosteroids-and their activities prompted significant efforts by organic chemists that resulted in many strategically compelling laboratory syntheses of these targets. These different strategies are compared and contrasted in this Microreview, and the authors' recent work on the structurally different but biogenetically related natural product exiguaquinol is put into the context of the previous studies on halenaquinol-type targets.

Entities:  

Keywords:  Cycloaddition; Diels–Alder; Heck reactions; Heterocyclic chemistry; electrophilic compounds; natural products; total synthesis

Year:  2017        PMID: 29527124      PMCID: PMC5841243          DOI: 10.1002/ejoc.201601418

Source DB:  PubMed          Journal:  European J Org Chem        ISSN: 1099-0690


  25 in total

1.  Synthesis of Functionalized Naphthalenes from Substituted 1-Methoxybenzocyclobutenes.

Authors:  Neil G. Andersen; Shawn P. Maddaford; Brian A. Keay
Journal:  J Org Chem       Date:  1996-04-19       Impact factor: 4.354

2.  Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction.

Authors:  M P Wymann; G Bulgarelli-Leva; M J Zvelebil; L Pirola; B Vanhaesebroeck; M D Waterfield; G Panayotou
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

3.  Intramolecular vinyl quinone Diels-Alder reactions: asymmetric entry to the cordiachrome core and synthesis of (-)-isoglaziovianol.

Authors:  Florian Löbermann; Lara Weisheit; Dirk Trauner
Journal:  Org Lett       Date:  2013-08-20       Impact factor: 6.005

4.  Design of inhibitors of Helicobacter pylori glutamate racemase as selective antibacterial agents: incorporation of imidazoles onto a core pyrazolopyrimidinedione scaffold to improve bioavailabilty.

Authors:  Gregory S Basarab; Pamela Hill; Charles J Eyermann; Madhu Gowravaram; Helena Käck; Ekundayo Osimoni
Journal:  Bioorg Med Chem Lett       Date:  2012-07-20       Impact factor: 2.823

5.  New bioactive halenaquinone derivatives from South Pacific marine sponges of the genus Xestospongia.

Authors:  Arlette Longeon; Brent R Copp; Mélanie Roué; Joëlle Dubois; Alexis Valentin; Sylvain Petek; Cécile Debitus; Marie-Lise Bourguet-Kondracki
Journal:  Bioorg Med Chem       Date:  2010-06-25       Impact factor: 3.641

6.  Inhibition of the phagocytosis-induced respiratory burst by the fungal metabolite wortmannin and some analogues.

Authors:  M Baggiolini; B Dewald; J Schnyder; W Ruch; P H Cooper; T G Payne
Journal:  Exp Cell Res       Date:  1987-04       Impact factor: 3.905

7.  A Synthesis of Exiguaquinol Dessulfate.

Authors:  Gregg M Schwarzwalder; David R Scott; Christopher D Vanderwal
Journal:  Chemistry       Date:  2016-10-26       Impact factor: 5.236

8.  Synthesis and biological evaluation of synthetic viridins derived from C(20)-heteroalkylation of the steroidal PI-3-kinase inhibitor wortmannin.

Authors:  Peter Wipf; Daniel J Minion; Robert J Halter; Margareta I Berggren; Caroline B Ho; Gary G Chiang; Lynn Kirkpatrick; Robert Abraham; Garth Powis
Journal:  Org Biomol Chem       Date:  2004-06-14       Impact factor: 3.876

9.  Vinyl quinones as Diels-Alder dienes: concise synthesis of (-)-halenaquinone.

Authors:  Michael A Kienzler; Sandy Suseno; Dirk Trauner
Journal:  J Am Chem Soc       Date:  2008-06-13       Impact factor: 15.419

10.  Synthesis of (+/-)-thiohalenaquinone by iterative metalations of thiophene.

Authors:  Bryan Wakefield; Robert J Halter; Peter Wipf
Journal:  Org Lett       Date:  2007-07-14       Impact factor: 6.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.